Circassia brings biotech craze from US to London

GLOBALCAPITAL INTERNATIONAL LIMITED, a company

incorporated in England and Wales (company number 15236213),

having its registered office at 4 Bouverie Street, London, UK, EC4Y 8AX

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement | Event Participant Terms & Conditions

Cookies Settings
Equity
Equity IPOs

Circassia brings biotech craze from US to London

Andrew Griffin
February 07, 2014 12:00 AM

Circassia launched the first large biotechnology IPO in London on Thursday after a run of listings from the sector in the US. The UK company, which hopes to find a cure for cat allergies, is set to raise £175m through the deal.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Request a Free Trial or Login

Topics

JP MorganEquity IPOsNews contentEquity
AG
Andrew Griffin
Gift this article